Dietary transforming growth factor-beta 2 (TGF-β2) supplementation reduces methotrexate-induced intestinal mucosal injury in a rat

PLoS One. 2012;7(9):e45221. doi: 10.1371/journal.pone.0045221. Epub 2012 Sep 12.

Abstract

Background/aims: Dietary supplementation with transforming growth factor-beta (TGF-β) has been proven to minimize intestinal damage and facilitate regeneration after mucosal injury. In the present study, we evaluated the effects of oral TGF-β2 supplementation on intestinal structural changes, enterocyte proliferation and apoptosis following methotrexate (MTX)-induced intestinal damage in a rat and in a cell culture model.

Methods: Caco-2 cells were treated with MTX and were incubated with increasing concentrations of TGF-β2. Cell apoptosis was assessed using FACS analysis by annexin staining and cell viability was monitored using Trypan Blue assay. Male rats were divided into four experimental groups: Control rats, CONTR- TGF-β rats were treated with diet enriched with TGF-β2, MTX rats were treated with a single dose of methotrexate, and MTX- TGF-β rats were treated with diet enriched with TGF-β2. Intestinal mucosal damage, mucosal structural changes, enterocyte proliferation and enterocyte apoptosis were determined at sacrifice. Real Time PCR and Western blot were used to determine bax and bcl-2 mRNA, p-ERK, β-catenin, IL-1B and bax protein expression.

Results: Treatment of MTX-pretreated Caco-2 cells with TGF-B2 resulted in increased cell viability and decreased cell apoptosis. Treatment of MTX-rats with TGF-β2 resulted in a significant increase in bowel and mucosal weight, DNA and protein content, villus-height (ileum), crypt-depth (jejunum), decreased intestinal-injury score, decreased level of apoptosis and increased cell proliferation in jejunum and ileum compared to the untreated MTX group. MTX-TGF-β2 rats demonstrated a lower bax mRNA and protein levels as well as increased bcl-2 mRNA levels in jejunum and ileum compared to MTX group. Treatment with TGF-β2 also led to increased pERK, IL-1B and β-catenin protein levels in intestinal mucosa.

Conclusions: Treatment with TGF-β2 prevents mucosal-injury, enhances p-ERK and β-catenin induced enterocyte proliferation, inhibits enterocyte apoptosis and improves intestinal recovery following MTX-induced intestinal-mucositis in rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / toxicity
  • Apoptosis / drug effects
  • Blotting, Western
  • Body Weight / drug effects
  • Caco-2 Cells
  • Cell Survival / drug effects
  • Dietary Supplements
  • Enterocytes / drug effects
  • Enterocytes / metabolism
  • Enterocytes / pathology
  • Humans
  • Interleukin-1beta / metabolism
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology
  • Male
  • Methotrexate / toxicity*
  • Mucositis / chemically induced
  • Mucositis / metabolism
  • Mucositis / prevention & control*
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Transforming Growth Factor beta / metabolism
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transforming Growth Factor beta2 / administration & dosage
  • Transforming Growth Factor beta2 / genetics
  • Transforming Growth Factor beta2 / pharmacology*
  • bcl-2-Associated X Protein / genetics
  • bcl-2-Associated X Protein / metabolism
  • beta Catenin / metabolism

Substances

  • Antimetabolites, Antineoplastic
  • Interleukin-1beta
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Transforming Growth Factor beta
  • Recombinant Proteins
  • Transforming Growth Factor beta2
  • bcl-2-Associated X Protein
  • beta Catenin
  • Methotrexate

Grants and funding

This work was supported by a research grant from Israeli Ministry of Health No 3/6164 from 01/06/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.